Merck & Co., Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 16.29B | 16.32B | 17.18B | 15.80B | 15.62B | 15.62B | 16.66B | 16.11B |
| Cost of Goods Sold | 2.94B | 4.82B | 4.19B | 3.85B | 3.88B | 3.83B | 4.08B | 3.75B |
| Gross Profit | 13.34B | 11.51B | 12.99B | 11.95B | 11.73B | 11.80B | 12.58B | 12.37B |
| R&D Expenses | 12.56B | 2.50B | 3.55B | 3.54B | 3.12B | 4.58B | 5.86B | 3.50B |
| Operating Expenses | 15.23B | 5.35B | 5.53B | 5.59B | 5.02B | 7.45B | 8.59B | 6.24B |
| Operating Income | -1.88B | 6.16B | 7.46B | 6.36B | 6.71B | 4.35B | 3.98B | 6.13B |
| Other Income / Gains | -1.65B | -2.74B | -718.0M | -1.36B | -807.0M | -178.0M | 106.0M | -122.0M |
| Net Income | -4.24B | 2.96B | 5.79B | 4.43B | 5.08B | 3.74B | 3.16B | 5.46B |
| EPS (Diluted) | -1.72 | 1.20 | 2.32 | 1.76 | 2.01 | 1.48 | 1.25 | 2.15 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.819 | 0.705 | 0.756 | 0.757 | 0.751 | 0.755 | 0.755 | 0.768 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 291.0M | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 2.40B | 0 | 0 |
| Selling General And Administrative Expenses | 2.67B | 2.85B | 1.97B | 2.05B | 1.91B | 2.69B | 2.73B | 2.74B |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 173.0M | 0 | 0 |
| Cost And Expenses | 18.17B | 10.16B | 9.72B | 9.44B | 8.91B | 11.28B | 12.67B | 9.98B |
| Interest Income | 0 | 69.0M | 96.0M | 69.0M | 109.0M | 146.0M | 127.0M | 69.0M |
| Interest Expense | 0 | 411.0M | 327.0M | 305.0M | 313.0M | 328.0M | 330.0M | 310.0M |
| Depreciation And Amortization | 0 | 2.47B | 1.07B | 1.06B | 1.10B | 1.20B | 1.19B | 1.13B |
| Ebitda | -1.88B | 8.63B | 8.54B | 7.42B | 7.81B | 5.70B | 5.61B | 7.45B |
| Ebitdaratio | -0.116 | 0.528 | 0.497 | 0.469 | 0.50 | 0.365 | 0.337 | 0.462 |
| Operating Income Ratio | -0.116 | 0.377 | 0.434 | 0.402 | 0.43 | 0.278 | 0.239 | 0.38 |
| Income Before Tax | -3.53B | 3.42B | 6.75B | 5.00B | 5.90B | 4.17B | 4.09B | 6.01B |
| Income Before Tax Ratio | -0.217 | 0.21 | 0.393 | 0.316 | 0.378 | 0.267 | 0.246 | 0.373 |
| Income Tax Expense | 709.0M | 458.0M | 958.0M | 571.0M | 818.0M | 426.0M | 929.0M | 545.0M |
| Net Income Ratio | -0.26 | 0.182 | 0.337 | 0.28 | 0.325 | 0.24 | 0.19 | 0.339 |
| Epsdiluted | -1.72 | 1.19 | 2.32 | 1.76 | 2.01 | 1.48 | 1.24 | 2.14 |
| Weighted Average Shs Out | 2.47B | 2.47B | 2.50B | 2.51B | 2.52B | 2.54B | 2.54B | 2.53B |
| Weighted Average Shs Out Dil | 2.47B | 2.49B | 2.50B | 2.51B | 2.53B | 2.54B | 2.54B | 2.54B |